PCM
ELEV

Prelude Capital Management’s Elevation Oncology ELEV Stock Holding History

Prelude Capital Management’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,240
Closed -$7.34K – 1165
2024
Q3 		$7.34K Sell
12,240
-79,754
-87% -$47.8K ﹤0.01% 1131
2024
Q2 		$248K Sell
91,994
-8,308
-8% -$22.4K 0.02% 802
2024
Q1 		$515K Buy
+100,302
New +$515K 0.03% 557